Institut Curie is creating a new integrated oncopediatrics center: SIREDO "Soins, Innovation, Recherche en oncologie de l'Enfant, l'aDOlescent et de l'adulte jeune" (Care, Innovation, Research in child, adolescent and young adult oncology). The center is led by Olivier Delattre and the steering committee (François Doz, Daniel Orbach and Gudrun Schleiermacher, respectively assistant directors in training, clinical research, care and translational research).
This center, bringing together researchers and clinicians, is based on several key SIRIC players in particular Gudrun Schleiermacher and Franck Bourdeaut, heads of the SIRIC RTOP team.
SIREDO research projects will build on the results of SIRIC research on Ewing tumors, neuroblastomas, rhabdoid tumors (Grünewald et al, Nat Genet, 2015; Sheffield et al, Nat Med, 2017; Tirode et al, Cancer Dis, 2014 ; Tauziède-Espariat et al, Eur J Hum Genet, 2017; Bertrand et al, Neuropathol Appl Neurobiol., 2017; Chauvin et al, Cell Rep., 2017) but also on clinical studies such as MAPPYACTS and MICCHADO that recevied SIRIC support.
The SIREDO center illustrates the strong leverage effect of the SIRIC label!